PlainPill

BPC-157 vs GHK-Cu for pain & inflammation

Short answer: For pain & inflammation, more users report improvement with GHK-Cu — 89% of 28 reports, versus 84% of 377 for BPC-157.

BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; GHK-Cu has 0 and 1.

Based on 1,171 reports about BPC-157 and 457 about GHK-Cu. Not medical advice.

BPC-157
Peptide
GHK-Cu
Peptide
User score4754
Verdict
Mixed
Mostly positive
Positive
of reports that state an outcome
53%62%
Reports1,171457
ResearchDResearch: NoneCResearch: Limited
Meta-analyses / RCTs0 / 00 / 1
Mainly used for
Weight loss
% reporting improvement
70% (10)88% (8)
Appetite
% reporting improvement
70% (10)—
Focus
% reporting improvement
64% (28)75% (4)
Energy
% reporting improvement
59% (29)—
Sleep
% reporting improvement
71% (52)80% (5)
Anxiety
% reporting improvement
44% (57)50% (4)
Mood
% reporting improvement
58% (106)86% (7)
Memory
% reporting improvement
33% (3)—
Performance
% reporting improvement
93% (44)100% (5)
Recovery
% reporting improvement
96% (342)95% (21)
Pain & inflammation
% reporting improvement
84% (377)89% (28)
Digestion
% reporting improvement
82% (90)100% (4)
Libido
% reporting improvement
54% (13)—
Hormones
% reporting improvement
20% (5)—
Heart & lipids
% reporting improvement
46% (13)33% (3)
Skin & hair
% reporting improvement
89% (27)87% (193)
Immunity
% reporting improvement
62% (8)100% (4)
Longevity
% reporting improvement
—100% (2)
Common side effectsanhedonia, fatigue, anxiety, depressioninjection site, redness, stinging, injection pain
Typical dose reportedNot listedNot listed
BPC-157
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
Full BPC-157 profile →
GHK-Cu
What a user said
“Love it. 44 F. Totally helped even out my skin tone (Irish red cheeks), reduced wrinkles on my forehead and neck, thickened my hair which had been thinning, and grew my eye lashes.”
Full GHK-Cu profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate